-
Forward Look
Breaking Down Breakthrough Cancer TherapiesDrugs approved through this pathway may have limited evidence.
by Lindsey Konkel
-
Policy Matters
Public Funding is the Lifeblood of Cancer ResearchLet your voice be heard in support of robust, sustained and predictable federal funding increases.
by George D. Demetri, MD
-
Reinforcements for Cancer Research
Scientific meeting emphasizes the importance of patient advocates in helping researchers to reduce cancer health disparities.
by Marci A. Landsmann
-
Does Medicaid Expansion Have an Impact?
Analysis suggests states that opted for Medicaid expansion had higher use of hormone therapy for breast cancer patients.
by Marci A. Landsmann
-
Achieving Health Equality
National Cancer Institute director Norman “Ned” Sharpless describes the challenge and opportunity of studying cancer disparities.
by Marci A. Landsmann
-
An Uncommon Partnership
Through the Angiosarcoma Project, researchers are partnering with patients to learn about a rare cancer.
by Ashley P. Taylor
-
Vaccinating Against Cancer
The human papillomavirus vaccine can significantly cut recipients' risk of several types of cancer. So why are vaccination rates relatively low in the U.S.?
by Brad Jones
-
Forward Look
FDA Acts to Curb Nicotine UseEfforts focus on cigarettes and new smokeless tobacco products.
by Brad Jones
-
Policy Matters
A Growing Commitment to Cancer SurvivorsThe number of cancer survivors is growing. We must step up efforts to meet their needs.
by Elizabeth M. Jaffee, MD
-
Get Involved
Helping Kids CopeHelp with Hope delivers care packages to young people whose mother or father has received a cancer diagnosis.
by Lindsey Konkel
Cancer Talk
Declining Breast Cancer Mortality in Younger Women
U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
Federal Support for Cancer Research Takes the Stage at AACR Annual MeetingScientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin